[contentcards url=”https://childrenshealthdefense.org/defender/rsv-monoclonal-antibody-shot-linked-drug-resistant-rsv-strains-infants/” target=”_blank”] by Brenda Baletti, Ph.D. A “substantial proportion” of infants immunized against the RSV virus with the monoclonal antibody shot nirsevimab — marketed by Sanofi and…